Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 6, 2026
Mar. 6, 2026
Why Video Marketing Continues to Dominate in 2026 — And How Video Plus Print Is Changing the Game
Indeterminate
EIN Presswire
Mar. 6, 2026
Enroll Prime Alternative Health Contracting 2026 Expansion Through FMO BenaVest
Indeterminate
EIN Presswire
Mar. 6, 2026
SourceFuse Announces Partnership with Databricks to Accelerate Global Data & AI Transformation
Indeterminate
EIN Presswire
Mar. 6, 2026
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Indeterminate
GlobeNewswire
Mar. 6, 2026
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
Crescent Biopharma Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
Mar. 6, 2026
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
Spyre Therapeutics Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
Mar. 6, 2026
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 6, 2026
CAMP4 to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
Mar. 6, 2026
Galapagos Creates New Subscription Right Plan
Indeterminate
GlobeNewswire
Mar. 6, 2026
Galapagos creëert nieuw inschrijvingsrechtenplan
Indeterminate
GlobeNewswire
Mar. 6, 2026
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire